ARCHIVES

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy

May 27, 1983

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

Virus Program Report On Scientific Activities

August 8, 1975

NIH to Hold Meeting On Faculty Design

February 2, 1996

Kennedy Bills Would Authorize Senior Scientist Service, New Foundation, Construction Grants

July 28, 1989

French Legion d’Honneur Bestowed On Hortobagyi.

March 1, 2002